Patents by Inventor Young Ran Um

Young Ran Um has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11123388
    Abstract: Provided is a pharmaceutical composition for preventing or treating inflammatory bowel disease (IBD) comprising a mixed extract of at least two of Aucklandia lappa Decne, Terminalia chebula Retzius, and Zingiber officinale Rosc. as an active ingredient and a method thereof, and more specifically, to a pharmaceutical composition having an inhibitory effect on monocyte adhesion in intestinal epithelial cells, an effect of inhibiting the production of inflammatory cytokines, an effect of ameliorating colitis in an animal model of dextran sodium sulfate (DSS)-induced colitis, and an effect of ameliorating Crohn's disease in an animal model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced Crohn's disease.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: September 21, 2021
    Assignee: GENUONE SCIENCES INC.
    Inventors: Yong-baik Cho, Seul-ki Kim, Sang-Back Kim, Jae-hyuck Shin, Young-ran Um, So-youn Mok, Ju-ri Jung, Soon-min Lim, Chae Shin Seo, Hong Koo Cho, Bon Am Koo, Hyo Jin Jeon, Han-Seok Choi, Ye Jin Kim
  • Publication number: 20180303888
    Abstract: Provided is a pharmaceutical composition for preventing or treating inflammatory bowel disease (IBD) comprising a mixed extract of at least two of Aucklandia lappa Decne, Terminalia chebula Retzius, and Zingiber officinale Rosc. as an active ingredient and a method thereof, and more specifically, to a pharmaceutical composition having an inhibitory effect on monocyte adhesion in intestinal epithelial cells, an effect of inhibiting the production of inflammatory cytokines, an effect of ameliorating colitis in an animal model of dextran sodium sulfate (DSS)-induced colitis, and an effect of ameliorating Crohn's disease in an animal model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced Crohn's disease.
    Type: Application
    Filed: November 4, 2016
    Publication date: October 25, 2018
    Inventors: Yong-baik CHO, Seul-ki KIM, Sang-Back KIM, Jae-hyuck SHIN, Young-ran UM, So-youn MOK, Ju-ri JUNG, Soon-min LIM, Chae Shin SEO, Hong Koo CHO, Bon Am KOO, Hyo Jin JEON, Han-Seok CHOI, Ye Jin KIM
  • Patent number: 9549961
    Abstract: The present invention relates to lactic acid fermented Galgeuntang, and a composition comprising the said lactic acid bacteria fermented Galgeuntang or Galgeuntang as an active ingredient, more particularly, to lactic acid fermented Galgeuntang prepared by the steps of inoculating lactic acid bacteria to Galgeuntang, culturing thereof, and fermenting thereof, and a composition for preventing or treating liver toxicity comprising the said fermented Galgeuntang or Galgeuntang. The composition of the present invention has treatment effect on liver toxicity, so that it can be effectively used as a liver function recovering agent or health food for liver function recovery.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: January 24, 2017
    Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Yeul Ma, Jae Hoon Lee, Young Ran Um, Ji Hye Lee
  • Patent number: 9295704
    Abstract: The present invention relates to a pharmaceutical composition and health supplement for preventing or treating atopic dermatitis, the composition and supplement having as active ingredients extract of a galenical mixture including sophora root, licorice, lonicer aflower, Korean angelica root, Korean aralia root, saussurea root, seselos radix, zizyphus spinosi, Houttuynia cordata, forsythia fruit, lappa fruit, Epimedium koreanum Nakai, ginseng, lithospermum, oleoresin, cnidium, scorophulariae radix, and reynoutria, or lactobacillus fermentation of the galenical extract prepared by inoculating lactobacillus to the galenical extract and fermenting same.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: March 29, 2016
    Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Yeul Ma, Tae Ho Chung, Ga Young Im, Dong Seon Kim, Young Ran Um, Hyun Ae Eum, Jae Hoon Lee, Sung Up Choi, Byoung Heon Cho
  • Patent number: 8623426
    Abstract: The present invention relates to herbal medicine extracts useful in the prevention or treatment of diseases caused by influenza viruses, and to a pharmaceutical composition or health food comprising the extracts. The herbal medicine extracts of the present invention are derived from natural materials, and are safe for the human body, and can be used in preventing and treating and in relieving symptoms of diseases caused by various types of influenza viruses.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: January 7, 2014
    Assignee: Korea Institute of Oriental Medicine
    Inventors: Jin Yeul Ma, Young Ran Um, Jae Hoon Lee, Hwa Yong Park
  • Patent number: 8591962
    Abstract: The present invention relates to a medicinal extract useful for preventing and treating influenza-virus-induced diseases, and to a pharmaceutical composition and health food including same. Derived from natural ingredients, the medicinal extract of the present invention is safe for humans, and can be used to prevent, treat, and alleviate symptoms of diseases induced by various strains of influenza viruses.
    Type: Grant
    Filed: January 7, 2010
    Date of Patent: November 26, 2013
    Assignee: Korea Institute of Oriental Medicine
    Inventors: Jin Yeul Ma, Young Ran Um, Ji Hye Lee
  • Publication number: 20130287761
    Abstract: The present invention relates to lactic acid fermented Galgeuntang, and a composition comprising the said lactic acid bacteria fermented Galgeuntang or Galgeuntang as an active ingredient, more particularly, to lactic acid fermented Galgeuntang prepared by the steps of inoculating lactic acid bacteria to Galgeuntang, culturing thereof, and fermenting thereof, and a composition for preventing or treating liver toxicity comprising the said fermented Galgeuntang or Galgeuntang. The composition of the present invention has treatment effect on liver toxicity, so that it can be effectively used as a liver function recovering agent or health food for liver function recovery.
    Type: Application
    Filed: June 25, 2013
    Publication date: October 31, 2013
    Inventors: Jin Yeul MA, Jae Hoon LEE, Young Ran UM, Ji Hye LEE
  • Publication number: 20130224181
    Abstract: The present invention relates to a pharmaceutical composition and health supplement for preventing or treating atopic dermatitis, the composition and supplement having as active ingredients extract of a galenical mixture including sophora root, licorice, lonicer aflower, Korean angelica root, Korean aralia root, saussurea root, seselos radix, zizyphus spinosi, Houttuynia cordata, forsythia fruit, lappa fruit, Epimedium koreanum Nakai, ginseng, lithospermum, oleoresin, cnidium, scorophulariae radix, and reynoutria, or lactobacillus fermentation of the galenical extract prepared by inoculating lactobacillus to the galenical extract and fermenting same.
    Type: Application
    Filed: October 29, 2010
    Publication date: August 29, 2013
    Applicant: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Yeul Ma, Tae Ho Chung, Ga Young Im, Dong Seon Kim, Young Ran Um, Hyun Ae Eum, Jae Hoon Lee, Sung Up Choi, Byoung Heon Cho
  • Publication number: 20120282354
    Abstract: The present invention relates to herbal medicine extracts useful in the prevention or treatment of diseases caused by influenza viruses, and to a pharmaceutical composition or health food comprising the extracts. The herbal medicine extracts of the present invention are derived from natural materials, and are safe for the human body, and can be used in preventing and treating and in relieving symptoms of diseases caused by various types of influenza viruses.
    Type: Application
    Filed: October 29, 2010
    Publication date: November 8, 2012
    Applicant: Korea Institute of Oriental Medicine
    Inventors: Jin Yeul Ma, Young Ran Um, Jae Hoon Lee, Hwa Yong Park
  • Publication number: 20120276223
    Abstract: The present invention relates to a medicinal extract useful for preventing and treating influenza-virus-induced diseases, and to a pharmaceutical composition and health food including same. Derived from natural ingredients, the medicinal extract of the present invention is safe for humans, and can be used to prevent, treat, and alleviate symptoms of diseases induced by various strains of influenza viruses.
    Type: Application
    Filed: January 7, 2010
    Publication date: November 1, 2012
    Applicant: Korea Institute of Oriental Medicine
    Inventors: Jin Yeul Ma, Young Ran Um, Ji Hye Lee
  • Publication number: 20120183526
    Abstract: The present invention relates to lactic acid fermented Galgeuntang, and a composition comprising the said lactic acid bacteria fermented Galgeuntang or Galgeuntang as an active ingredient, more particularly, to lactic acid fermented Galgeuntang prepared by the steps of inoculating lactic acid bacteria to Galgeuntang, culturing thereof, and fermenting thereof, and a composition for preventing or treating liver toxicity comprising the said fermented Galgeuntang or Galgeuntang. The composition of the present invention has treatment effect on liver toxicity, so that it can be effectively used as a liver function recovering agent or health food for liver function recovery.
    Type: Application
    Filed: September 25, 2009
    Publication date: July 19, 2012
    Applicant: Korea Institute of Oriental Medicine
    Inventors: Jin Yeul Ma, Jae Hoon Lee, Young Ran Um, Ji Hye Lee